ARTICLE | Company News
Approvable letter for SKP's UroXatral
October 10, 2001 7:00 AM UTC
SkyePharma (SKYE; LSE:SKP) and Sanofi- Synthelabo (Paris, France) received an approvable letter from the FDA for UroXatral, a once daily formulation of Sanofi's alfuzosin uroselective alpha1-blocker t...